Macrocure Hires Lewis Gryziewicz as Vice President, Regulatory Affairs
May 04, 2015 08:00 ET
|
Macrocure
PETACH TIKVA, Israel, May 4, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. to Participate in Upcoming Annual Meeting of The Association for Research in Vision & Ophthalmology (ARVO)
April 28, 2015 08:00 ET
|
Macrocure
PETACH TIKVA, Israel, April 28, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. Announces First Quarter 2015 Financial Results Date and Conference Call
April 21, 2015 08:00 ET
|
Macrocure
PETACH TIKVA, Israel, April 21, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. to Participate in Upcoming Symposium on Advanced Wound Care
April 13, 2015 09:00 ET
|
Macrocure
PETACH TIKVA, Israel, April 13, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Ltd. Provides Corporate Update and Reports Fourth Quarter and Full Year 2014 Financial Results
March 17, 2015 16:05 ET
|
Macrocure
—Company announces anticipated timeline for DFU Phase III clinical trial results—
—Company accelerates timelines for VLU Phase III clinical trial...
Macrocure Hires Dr. Ramesh Tharuvai, Ph.D. as Vice President, Operations
March 02, 2015 06:00 ET
|
Macrocure
PETACH TIKVA, Israel, March 2, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure Ltd. Announces Fourth Quarter and Full Year 2014 Financial Results Date and Conference Call
February 25, 2015 08:00 ET
|
Macrocure
PETACH TIKVA, Israel, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure Hires Mark Page as Chief Financial Officer
February 09, 2015 04:05 ET
|
Macrocure
PETACH TIKVA, Israel, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure Announces Special General Meeting of Shareholders for Approval of Amendments to Compensation Package of CEO and 2013 Share Incentive Plan
February 05, 2015 12:00 ET
|
Macrocure
PETACH TIKVA, Israel, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure Ltd. to Present at 17th Annual BIO CEO & Investor Conference
January 27, 2015 08:00 ET
|
Macrocure
PETACH TIKVA, Israel, Jan. 27, 2015 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...